Kunitachi, Japan

Ikuo Kimura

This inventor holds 1 USPTO granted patent. Top assignee: Noster Inc.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ikuo Kimura. Retrieved from https://idiyas.com/inventor/ikuo-kimura-o3ttbhlg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ikuo Kimura: Innovator in Metabolic Disorder Treatments

Introduction

Ikuo Kimura is a notable inventor based in Kunitachi, Japan. He has made significant contributions to the field of metabolic disorder treatments through his innovative research and development.

Latest Patents

Ikuo Kimura holds a patent for a composition aimed at preventing or treating metabolism disorders. This composition includes leuconostoc mesenteroides-producing exopolysaccharide as an active ingredient. The invention provides a prophylactic or therapeutic composition for metabolic disorders, a composition for amplifying the amount of short-chain fatty acids in the intestine, and a composition for decreasing the ratio of Firmicutes to Bacteroidetes bacteria in the intestine. Each of these compositions contains an exopolysaccharide produced by the mentioned bacteria, along with applications in food, pharmaceuticals, and feed.

Career Highlights

Ikuo Kimura is associated with Noster Inc., where he continues to advance his research in metabolic health. His work has the potential to impact various industries, including healthcare and nutrition.

Collaborations

Ikuo collaborates with notable colleagues such as Kenji Yamamoto and Keiko Hisa, contributing to a dynamic research environment.

Conclusion

Ikuo Kimura's innovative work in developing treatments for metabolic disorders showcases his commitment to improving health outcomes. His contributions are significant in the ongoing quest for effective solutions in this critical area of health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…